- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2 Breast Cancer
Total 89109 results
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Breast CancerChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedRecruitingBreast Cancer | RadiotoxicityChina
-
Imperial College LondonMedical Research Council; University of CambridgeRecruiting
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Solid Tumor | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cancer of the Salivary GlandUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Prof. Wolfgang JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHActive, not recruiting
-
MedSIRNovartisActive, not recruiting
-
Bolt Biotherapeutics, Inc.Bristol-Myers SquibbActive, not recruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial CancerFrance, United States, Spain, Korea, Republic of, Italy
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
Herbert LyerlyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | HER2+ Breast CancerUnited States
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | NSCLCUnited States
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
Zymeworks Inc.Active, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of, Australia
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
University of New MexicoWithdrawnBreast CancerUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedCompleted
-
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyAstraZenecaCompletedNeoplasm, Breast | Adenocarcinoma, GastricTaiwan
-
Sandra SwainGenentech, Inc.; Medstar Health Research Institute; Lombardi Comprehensive Cancer... and other collaboratorsCompletedDiarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients (HALT-D)Breast CancerUnited States
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
OmicsWay Corp.Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary...Active, not recruitingHER2-positive Breast CancerUnited States, Russian Federation
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Zai Lab (Shanghai) Co., Ltd.CompletedHER2 Positive Metastatic Breast CancerChina
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States
-
Novartis PharmaceuticalsCompletedBreast NeoplasmsUnited States, France, Spain, United Kingdom, Croatia, Turkey, Netherlands, Argentina, Australia, Canada, Czechia, Germany, Italy, Poland, Russian Federation, Brazil, Bulgaria, Chile, Denmark, Hungary, Ireland, Peru, South Africa, Col... and more
-
Fuda Cancer Hospital, GuangzhouWithdrawn
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedHER2-Positive Early Stage Breast CancerUnited States
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
H. Kim LyerlySusan G. Komen Breast Cancer FoundationCompleted
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Severance HospitalUnknownBreast CancerKorea, Republic of
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Genentech, Inc.Completed
-
University of VirginiaTerminatedBreast Cancer Female | Leptomeningeal MetastasesUnited States
-
Jules Bordet InstituteCompletedBreast Neoplasms | Secondary | HER2 Positive Carcinoma of BreastBelgium
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
SystImmune Inc.RecruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract CancerUnited States
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Taiwan, Australia, Singapore
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands, Italy